NRx Pharmaceuticals, Inc.

NasdaqGM:NRXP Stock Report

Mkt Cap: US$82.5m

NRx Pharmaceuticals Financial Health

How is NRx Pharmaceuticals's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: NRXP's short term assets ($24.8M) exceed its short term liabilities ($8.0M).

Long Term Liabilities: NRXP has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: NRXP is debt free.

Reducing Debt: NRXP had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: NRXP has sufficient cash runway for 5 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: NRXP is forecast to have sufficient cash runway for 4 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies